9-ING-41
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for 9-ING-41, covering 2024-02-07 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: 9-ING-41 in Patients With Advanced Cancers [Phase 2]